C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/423 (2006.01) A61K 31/4439 (2006.01) A61P 3/06 (2006.01) A61P 9/10 (2006.01) C07D 263/57 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2689525
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are potent CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In formula I, A-B is an arylamide moiety.
L'invention concerne des composés présentant une structure de formule I, ainsi que des sels acceptables sur le plan pharmaceutique desdits composés, qui sont de puissants inhibiteurs de CETP, qui sont utiles pour augmenter le HDL cholestérol, réduire le LDL cholestérol, et qui permettent de traiter ou de prévenir l'athérosclérose. Dans la formule I, A-B est un fragment arylamide.
Hunt Julianne A.
Sinclair Peter J.
Sweis Ramzi F.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Cetp inhibitors derived from benzoxazole arylamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cetp inhibitors derived from benzoxazole arylamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cetp inhibitors derived from benzoxazole arylamides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1744990